<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/65AF1713-F5D3-41D8-A71A-DA5E41A4F797"><gtr:id>65AF1713-F5D3-41D8-A71A-DA5E41A4F797</gtr:id><gtr:firstName>Vincenzo</gtr:firstName><gtr:surname>Cerundolo</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1000800"><gtr:id>C9BF0300-2C07-4CB1-867A-77E5B591AA28</gtr:id><gtr:title>University Unit Award MRC Human Immunology Unit</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000800</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The increasing globalisation of infectious disease is a major challenge to human health. The MRC Human Immunology Unit is a key player in international efforts to combat this threat, and in research into other diseases involving the immune system. The immune system is crucial to human health. Our ability to identify and destroy invading pathogens involves complex networks of interacting cells and molecules. Understanding precisely how the system works at the cellular, genetic and molecular levels will help in the development of new therapies for diseases such as AIDS, avian flu, multiple sclerosis, arthritis and eczema.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>8577908</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Sciences Division</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Role of lysosome in activation of specific pattern recognition receptors</gtr:description><gtr:id>8C65B750-6882-4781-AD27-D8D1F17A73F2</gtr:id><gtr:impact>This collaboration has resulted in the obtaining of a grant from a US based charity to financially support one aspect of the study and the results obtained to date are the basis of a recently-submitted grant application to MRC. An undergraduate project student is currently contributing to this research and a manuscript is in preparation.</gtr:impact><gtr:partnerContribution>Provision of expertise, animal models, co-writing of grant application that led to additional grant funding, co-applicant on successful application to industrial collaborator for provision of llcensed biologic drug which will be tested in the animal models.</gtr:partnerContribution><gtr:piContribution>Made a novel observation of aberrant activation of a pro-inflammatory innate immune mechanism in a mouse model of a glycosphingolipid storage disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Research Institute (LRI)</gtr:department><gtr:description>B cell biology and NKT cells</gtr:description><gtr:id>A1597736-D89E-4C80-9349-ECA4ADF0124F</gtr:id><gtr:impact>Publications:
20228797
18550831</gtr:impact><gtr:partnerContribution>Collaborative work on the interaction of the innate and adaptive immune responses has led to two publications. The collaborator studies the role of B cells in this interaction.</gtr:partnerContribution><gtr:piContribution>Collaborative work on the interaction of the innate and adaptive immune responses has led to two publications. We study the role of NKT cells in this interaction.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Vaccine Group</gtr:department><gtr:description>Collaboration with the Oxford Vaccine Group</gtr:description><gtr:id>8FF0EFA7-DA42-4D59-B15D-64306940F6A1</gtr:id><gtr:impact>Collaboration still ongoing</gtr:impact><gtr:partnerContribution>As a joint collaboration, we are investigating disease mechanisms in enteric fever to characterise innate and adaptive immunity in mucosa and blood in controlled human infection models</gtr:partnerContribution><gtr:piContribution>In the context of the MRC Experimental Medicine Challenge Grant, my group has set up a close collaboration with the Oxford Vaccine Group directed by Professor Andrew Pollard.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Role of novel scavenger receptor in inflammatory responses of human airways</gtr:description><gtr:id>05118E66-831F-4C3D-85B9-5C1FC7B4BD73</gtr:id><gtr:impact>These collaborative studies are in progress but we anticipate peer-reviewed publication(s) derived from these studies within the next twelve months.</gtr:impact><gtr:partnerContribution>In collaboration with Professor Donna Davies and Dr Marina Leino we are exploring the expression and biological activities of the novel scavenger receptor in the inflammatory responses of ex-vivo airway tissues from healthy and diseased donors.</gtr:partnerContribution><gtr:piContribution>We have provided expertise and knowledge as well as specific reagents to the collaboration to facilitate the studies of patient material obtained through clinical consultations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>A level student visits 2012</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FFD35A43-E1F3-4416-B07A-FB17718E2B33</gtr:id><gtr:impact>2 students were hosted by members of my group for a &amp;quot;work experience week'

school would like to repeat the program in 2013</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Annual Review 2008-09</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>614C1867-2A8A-4240-8FD6-41B0BF2409CD</gtr:id><gtr:impact>General description of the my research programme to a general audience

general interests towards the research programmes that we are developing in my laboratory and within the MRC Human Immunology Unit.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Work Experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>78732CE6-203A-4D0F-8115-A2A259FEA244</gtr:id><gtr:impact>Where possible within the constraints of Health &amp;amp; Safety, the Unit welcomes sixth form students to carry out their work experience within the Unit - undertaking simple practical techniques and shadowing Unit members to get a better appreciation of a career in medical research. One student spent 1 week working in my Lab.

School asked for future opportunities</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Magadalen College School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6CB050F6-4B9D-49F0-B255-2B48BD943EF8</gtr:id><gtr:impact>Prof. Cerundolo gave a lecture at Magadalen College School, Oxford to 130 17-year olds on the career path of scientists in which he described training and job opportunities in biomedical research

School interested in future visits</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford University Department for Continuing Education Human and Veterinary Vaccinology Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>06B17468-68A5-47C8-8A20-60A0D4C83C70</gtr:id><gtr:impact>During the last 2 years, the Oxford University Department for Continuing Education http://www.conted.ox.ac.uk/courses/C900-1 
has launched a leading educational programme in Vaccinology, tailored to the needs of industry in the UK and beyond, by sharing the expertise of several investigators, both at the Institute for Animal Health and across the University of Oxford, complemented by the views and experience of distinguished outside speakers. The courses run in 2010 were fully subscribed and received very good feedback from the participants. The satisfaction scores were very high: 88% for the Human and Veterinary Vaccinology; 77% for the Clinical Vaccine Development course; and 81% for the Vaccine Biomanufacturing course.
In November 2011 Prof. Cerundolo gave a talk entitled 'An Introduction to Tumour Immunology'

Course was well attended</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Alumni</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EA3FC377-0AC0-400D-AA20-FD6758213404</gtr:id><gtr:impact>Prof. Cerundolo gave a lecture on tumour immunology and cancer vaccines to a group of 130 Oxford Alumni (average age 60 years)

Talk was well received</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK funding (Analysis of tumour-specific responses in cancer patients)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>59CA61E8-4CED-446A-943B-751D4E4B046C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214358</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Department of Health Experimental Cancer Medicine Centre: Tumour Immunology Translational Programme</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Experimental Cancer Medicine Centre Network (ECMC)</gtr:fundingOrg><gtr:id>F1FE7AFA-DDEE-4D46-866B-E0C47AA2951C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Oxford Cancer Imaging Centre Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>C2C7F38C-AC77-4A0E-A3C7-775DF60CECF0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research Institute USA (Affinity maturated NY-ESO-1 157-165/HLA-A2 specific antibodies for targeting and detection of NY-ESO-1 expressing tumours)</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Cancer Research Institute (CRI)</gtr:fundingOrg><gtr:id>293F5F64-7078-4C9B-A386-9D5D0E3F27CE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Euradrenal</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>5F9D72AD-0840-4B6D-832B-1A8D0AA3912F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research Institute USA (A phase I study of NY-ESO-1 ISCOM followed by recombinant fowlpox NY-ESO1 (rF-NY-ESO) in patients with NY-ESO-1 positive tumours)</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Cancer Research Institute (CRI)</gtr:fundingOrg><gtr:id>2647992B-94B0-49CB-84D4-50C34BED2019</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>490000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Ludwig Institute for Cancer Research (LICR)</gtr:department><gtr:description>LICR Collaborative Research</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Nuffield Department of Medicine</gtr:fundingOrg><gtr:id>01AB9339-FA15-4A34-BDED-0A6A82C12B93</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Oxford Cancer Imaging Centre</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>DBFE7C2D-76C3-4AE6-B21B-14E8CBFA224A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>2F838ADA-F8D2-4B64-A5AD-C7A01F2BFC19</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85AE247A-B615-410C-B4E2-22DC0E3BD6F8"><gtr:id>85AE247A-B615-410C-B4E2-22DC0E3BD6F8</gtr:id><gtr:title>Non-glycosidic compounds can stimulate both human and mouse iNKT cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b82391780be83628fc99fe5451faae5"><gtr:id>0b82391780be83628fc99fe5451faae5</gtr:id><gtr:otherNames>Jukes JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DBE420BC-EA82-4F70-A4EA-DF49C887853C"><gtr:id>DBE420BC-EA82-4F70-A4EA-DF49C887853C</gtr:id><gtr:title>IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49a45bc2b3cb7e3f4064a9dce2caec9a"><gtr:id>49a45bc2b3cb7e3f4064a9dce2caec9a</gtr:id><gtr:otherNames>Silk JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57D1AC60-D213-44A0-BBB7-EE179EB4F51C"><gtr:id>57D1AC60-D213-44A0-BBB7-EE179EB4F51C</gtr:id><gtr:title>Recent advances in processing and presentation of CD1 bound lipid antigens.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB333EDE-E341-4991-A56B-8AD1EB21EEC2"><gtr:id>CB333EDE-E341-4991-A56B-8AD1EB21EEC2</gtr:id><gtr:title>Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0B8993E-DC46-408A-9314-A93F46515156"><gtr:id>F0B8993E-DC46-408A-9314-A93F46515156</gtr:id><gtr:title>Chasing flies because time flies.</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/297e60d00493b61bbc3912f6acef33d8"><gtr:id>297e60d00493b61bbc3912f6acef33d8</gtr:id><gtr:otherNames>Herwald H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDEC7308-848C-4533-B99A-441BDB56C069"><gtr:id>FDEC7308-848C-4533-B99A-441BDB56C069</gtr:id><gtr:title>Human autoreactive T cells recognize CD1b and phospholipids.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d47083a7f870923cea9bf716967da545"><gtr:id>d47083a7f870923cea9bf716967da545</gtr:id><gtr:otherNames>Van Rhijn I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C25B7686-65EB-49A5-BE73-7E54EE5DD456"><gtr:id>C25B7686-65EB-49A5-BE73-7E54EE5DD456</gtr:id><gtr:title>Binding strength and dynamics of invariant natural killer cell T cell receptor/CD1d-glycosphingolipid interaction on living cells by single molecule force spectroscopy.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7a96225e57f23e027a96f9169f26cc"><gtr:id>1e7a96225e57f23e027a96f9169f26cc</gtr:id><gtr:otherNames>Bozna BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E7908F2-E963-4080-8F26-53A3F1724271"><gtr:id>0E7908F2-E963-4080-8F26-53A3F1724271</gtr:id><gtr:title>A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d54e30e2c879943d1c7bb02b8ac6559b"><gtr:id>d54e30e2c879943d1c7bb02b8ac6559b</gtr:id><gtr:otherNames>Hutchinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17699EFF-B315-4CD7-A7B0-6E4CB5D882E6"><gtr:id>17699EFF-B315-4CD7-A7B0-6E4CB5D882E6</gtr:id><gtr:title>The location of splenic NKT cells favours their rapid activation by blood-borne antigen.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed032268c749fe13105b28653a67c1d5"><gtr:id>ed032268c749fe13105b28653a67c1d5</gtr:id><gtr:otherNames>Barral P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8DB2D67-1E41-4F07-B8AE-62E8A9E3C239"><gtr:id>D8DB2D67-1E41-4F07-B8AE-62E8A9E3C239</gtr:id><gtr:title>Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d09a00d7c724d63247a15b7e5419d9c5"><gtr:id>d09a00d7c724d63247a15b7e5419d9c5</gtr:id><gtr:otherNames>De Santo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7937630C-3204-43E9-8D41-996B0C052098"><gtr:id>7937630C-3204-43E9-8D41-996B0C052098</gtr:id><gtr:title>The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6de2737c81a157a81c65fd17e9d448b5"><gtr:id>6de2737c81a157a81c65fd17e9d448b5</gtr:id><gtr:otherNames>Torreno-Pina JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C856E9B-8A32-4196-8E83-CD65E2314119"><gtr:id>4C856E9B-8A32-4196-8E83-CD65E2314119</gtr:id><gtr:title>Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a65f8968616393ae77c7eee04bbea2fd"><gtr:id>a65f8968616393ae77c7eee04bbea2fd</gtr:id><gtr:otherNames>Pei B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D1A2051-D3BF-4CFE-8879-30205C798A5E"><gtr:id>4D1A2051-D3BF-4CFE-8879-30205C798A5E</gtr:id><gtr:title>MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67f08f07df060c5266f71cbf63bc9e76"><gtr:id>67f08f07df060c5266f71cbf63bc9e76</gtr:id><gtr:otherNames>Howson LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52710D30-E776-4E8E-AB4E-A9B60A80A9FC"><gtr:id>52710D30-E776-4E8E-AB4E-A9B60A80A9FC</gtr:id><gtr:title>Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5253ccac976e8e8fdf9eba0567d80417"><gtr:id>5253ccac976e8e8fdf9eba0567d80417</gtr:id><gtr:otherNames>Kamaladasa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42C83A83-630B-439B-A07F-58C29FBF573F"><gtr:id>42C83A83-630B-439B-A07F-58C29FBF573F</gtr:id><gtr:title>Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2835E4E8-9E98-42BE-94BB-FCD3926DE438"><gtr:id>2835E4E8-9E98-42BE-94BB-FCD3926DE438</gtr:id><gtr:title>Bee venom processes human skin lipids for presentation by CD1a.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b35c1f191240d89a521fb16991424bd0"><gtr:id>b35c1f191240d89a521fb16991424bd0</gtr:id><gtr:otherNames>Bourgeois EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BCB98405-9BE1-4107-BBD6-7914D2674127"><gtr:id>BCB98405-9BE1-4107-BBD6-7914D2674127</gtr:id><gtr:title>Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric a-galactosyl ceramide analogues.</gtr:title><gtr:parentPublicationTitle>Carbohydrate research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3bc556e8a52dfe9b143535b3a1ef5857"><gtr:id>3bc556e8a52dfe9b143535b3a1ef5857</gtr:id><gtr:otherNames>Jervis PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0008-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A330225A-33E9-46A9-92E5-6C7919D62CBF"><gtr:id>A330225A-33E9-46A9-92E5-6C7919D62CBF</gtr:id><gtr:title>Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f71c646940318407a3861110bf2de944"><gtr:id>f71c646940318407a3861110bf2de944</gtr:id><gtr:otherNames>Porubsky S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FD04DB6-967A-4029-AA22-A64472BE726D"><gtr:id>4FD04DB6-967A-4029-AA22-A64472BE726D</gtr:id><gtr:title>CD1d-dependent endogenous and exogenous lipid antigen presentation.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d55e13bb2bca478bf77fd2f78fff1d1"><gtr:id>1d55e13bb2bca478bf77fd2f78fff1d1</gtr:id><gtr:otherNames>McEwen-Smith RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70B4337A-5677-4EDD-8CF3-E5D43926C619"><gtr:id>70B4337A-5677-4EDD-8CF3-E5D43926C619</gtr:id><gtr:title>Modulation of cancer-specific immune responses by amino acid degrading enzymes.</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/308df9ed4646591061d92bfb2f8f47f6"><gtr:id>308df9ed4646591061d92bfb2f8f47f6</gtr:id><gtr:otherNames>Timosenko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7496CB63-1263-473B-A812-9C86EE5949A1"><gtr:id>7496CB63-1263-473B-A812-9C86EE5949A1</gtr:id><gtr:title>Active nuclear transcriptome analysis reveals inflammasome-dependent mechanism for early neutrophil response to Mycobacterium marinum</gtr:title><gtr:parentPublicationTitle>Scientific Reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b56478981f0cc0b398ee81ce24b83b3d"><gtr:id>b56478981f0cc0b398ee81ce24b83b3d</gtr:id><gtr:otherNames>Kenyon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5DD21213-AF88-42F6-987E-91FE8BF38949"><gtr:id>5DD21213-AF88-42F6-987E-91FE8BF38949</gtr:id><gtr:title>NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b1d9c86788c1281ca4ae8c3808452fe"><gtr:id>2b1d9c86788c1281ca4ae8c3808452fe</gtr:id><gtr:otherNames>Davis LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E64CEDE-F9DC-4A82-8429-7286E4FFB116"><gtr:id>7E64CEDE-F9DC-4A82-8429-7286E4FFB116</gtr:id><gtr:title>NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.</gtr:title><gtr:parentPublicationTitle>Yeast (Chichester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d1ca22809264f6b5d96e05bb41b4190"><gtr:id>9d1ca22809264f6b5d96e05bb41b4190</gtr:id><gtr:otherNames>Wadle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0749-503X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E1F7E79-7268-46CF-83BD-E9C17C537B8B"><gtr:id>7E1F7E79-7268-46CF-83BD-E9C17C537B8B</gtr:id><gtr:title>Synthesis of truncated analogues of the iNKT cell agonist, a-galactosyl ceramide (KRN7000), and their biological evaluation.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b71cc096b28f5d38b81344d4bdd2b9bd"><gtr:id>b71cc096b28f5d38b81344d4bdd2b9bd</gtr:id><gtr:otherNames>Veerapen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FE13FAE-D42F-4C11-9F5C-2EC8753FD0BC"><gtr:id>4FE13FAE-D42F-4C11-9F5C-2EC8753FD0BC</gtr:id><gtr:title>BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccines.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3D34589-C1F0-449E-A740-F84444692CB3"><gtr:id>E3D34589-C1F0-449E-A740-F84444692CB3</gtr:id><gtr:title>B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CBAFA8C-5F20-42B6-9FA5-45FBCFB08E56"><gtr:id>2CBAFA8C-5F20-42B6-9FA5-45FBCFB08E56</gtr:id><gtr:title>Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.</gtr:title><gtr:parentPublicationTitle>Oncoimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b045ced11ecc86a5f60212689717498"><gtr:id>9b045ced11ecc86a5f60212689717498</gtr:id><gtr:otherNames>D?len Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2162-4011</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B1B2372-491E-46D4-ADE6-77542A06F463"><gtr:id>5B1B2372-491E-46D4-ADE6-77542A06F463</gtr:id><gtr:title>Kinetics and mechanics of two-dimensional interactions between T cell receptors and different activating ligands.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a0e94d1951bdc0c24b6d4977fd54a5a"><gtr:id>0a0e94d1951bdc0c24b6d4977fd54a5a</gtr:id><gtr:otherNames>Robert P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4980B4D3-4ECB-46A7-88FA-2C9804CC6C09"><gtr:id>4980B4D3-4ECB-46A7-88FA-2C9804CC6C09</gtr:id><gtr:title>Prostaglandin E2 suppresses the differentiation of retinoic acid-producing dendritic cells in mice and humans.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac7e26fc7687dfd51f87121e4632ed91"><gtr:id>ac7e26fc7687dfd51f87121e4632ed91</gtr:id><gtr:otherNames>Stock A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39E7720F-B94F-40C7-9234-5C8F703D9595"><gtr:id>39E7720F-B94F-40C7-9234-5C8F703D9595</gtr:id><gtr:title>Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/745674873575c58989eaec9fa740d98d"><gtr:id>745674873575c58989eaec9fa740d98d</gtr:id><gtr:otherNames>Stinchcombe JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/012A3E54-99A4-460D-AFBA-39A5B0BBF948"><gtr:id>012A3E54-99A4-460D-AFBA-39A5B0BBF948</gtr:id><gtr:title>Constitutively active Lck kinase in T cells drives antigen receptor signal transduction.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff1acd48b435d6ed60d479e0726c769f"><gtr:id>ff1acd48b435d6ed60d479e0726c769f</gtr:id><gtr:otherNames>Nika K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E79EDD63-349A-4F53-906B-A7FD6D0F5429"><gtr:id>E79EDD63-349A-4F53-906B-A7FD6D0F5429</gtr:id><gtr:title>Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.</gtr:title><gtr:parentPublicationTitle>Journal of pharmaceutical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26134f681f6cf55c84202737dc3ce3e7"><gtr:id>26134f681f6cf55c84202737dc3ce3e7</gtr:id><gtr:otherNames>Kaur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3549</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B093708-C23A-4B3E-88AA-EA70C885E21B"><gtr:id>7B093708-C23A-4B3E-88AA-EA70C885E21B</gtr:id><gtr:title>Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6fb13f7f6726d418d15c6c07708d5457"><gtr:id>6fb13f7f6726d418d15c6c07708d5457</gtr:id><gtr:otherNames>Wojno J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DCBA083E-3D59-414F-B126-F898EFC3FDB4"><gtr:id>DCBA083E-3D59-414F-B126-F898EFC3FDB4</gtr:id><gtr:title>Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/07fefc16726e8220ca1003792597d1ee"><gtr:id>07fefc16726e8220ca1003792597d1ee</gtr:id><gtr:otherNames>Nakaya HI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F04C5064-9EEC-47AD-863D-9ADEBEFBA2D5"><gtr:id>F04C5064-9EEC-47AD-863D-9ADEBEFBA2D5</gtr:id><gtr:title>T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74df5c84b51c02bff3ba1fbba395c41a"><gtr:id>74df5c84b51c02bff3ba1fbba395c41a</gtr:id><gtr:otherNames>Brodovitch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F334188-EF5A-42EB-8930-F7D9E94B8C5A"><gtr:id>7F334188-EF5A-42EB-8930-F7D9E94B8C5A</gtr:id><gtr:title>Failure to detect production of IL-10 by activated human neutrophils.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/962837fe8eeebd72e53c9816bd4f9676"><gtr:id>962837fe8eeebd72e53c9816bd4f9676</gtr:id><gtr:otherNames>Davey MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6353646D-D62C-48FE-86AF-4899C37C935F"><gtr:id>6353646D-D62C-48FE-86AF-4899C37C935F</gtr:id><gtr:title>Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6dd7df21beeebdf22230b26307bee08e"><gtr:id>6dd7df21beeebdf22230b26307bee08e</gtr:id><gtr:otherNames>Chang PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4D94A0E-019B-4798-98B7-C08B003889A8"><gtr:id>E4D94A0E-019B-4798-98B7-C08B003889A8</gtr:id><gtr:title>Erratum to: B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7994E6EF-CD58-40C4-9CF4-4D7AAB8F69F9"><gtr:id>7994E6EF-CD58-40C4-9CF4-4D7AAB8F69F9</gtr:id><gtr:title>Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2f2bd7f336da8c018723aeaf0de7f58"><gtr:id>f2f2bd7f336da8c018723aeaf0de7f58</gtr:id><gtr:otherNames>Dushek O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1213E097-F2A8-4101-BD19-82BC77FF9931"><gtr:id>1213E097-F2A8-4101-BD19-82BC77FF9931</gtr:id><gtr:title>Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/308df9ed4646591061d92bfb2f8f47f6"><gtr:id>308df9ed4646591061d92bfb2f8f47f6</gtr:id><gtr:otherNames>Timosenko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6C89C103-AE26-487C-AA64-8257B0CA2A47"><gtr:id>6C89C103-AE26-487C-AA64-8257B0CA2A47</gtr:id><gtr:title>Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9149911F-88E4-4D57-97EE-588BE1F1980A"><gtr:id>9149911F-88E4-4D57-97EE-588BE1F1980A</gtr:id><gtr:title>Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.</gtr:title><gtr:parentPublicationTitle>Journal of immunotherapy (Hagerstown, Md. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9fe1d78d9f73909aa0285fb1be6f87e2"><gtr:id>9fe1d78d9f73909aa0285fb1be6f87e2</gtr:id><gtr:otherNames>Mussai F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1524-9557</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/446D20DD-BD62-40B4-AD82-2726986834EE"><gtr:id>446D20DD-BD62-40B4-AD82-2726986834EE</gtr:id><gtr:title>Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bb9933d7677bfa255cf9e7b6cc37e5b"><gtr:id>6bb9933d7677bfa255cf9e7b6cc37e5b</gtr:id><gtr:otherNames>Poulin LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A904B1BB-0459-462C-811A-B609EE5F6A87"><gtr:id>A904B1BB-0459-462C-811A-B609EE5F6A87</gtr:id><gtr:title>Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20DB5625-D2B6-4C1B-BB05-7A9E5BFDA9CC"><gtr:id>20DB5625-D2B6-4C1B-BB05-7A9E5BFDA9CC</gtr:id><gtr:title>In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99E6AC68-A8EE-43C5-B0A5-A71A254E03F4"><gtr:id>99E6AC68-A8EE-43C5-B0A5-A71A254E03F4</gtr:id><gtr:title>Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/334bb3fa06ba7049928f293fe6c4d46a"><gtr:id>334bb3fa06ba7049928f293fe6c4d46a</gtr:id><gtr:otherNames>Silk KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000800</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>